Rapid determination of ADAMTS13 activity improves clinical decision-making

被引：2
|
作者：
Cataland, Spero R. [1 ]
Jin, Ming
Wu, Haifeng M.
机构：
[1] Ohio State Univ, Dept Med, Div Hematol Oncol, Med Ctr, Columbus, OH 43210 USA
[2] Ohio State Univ, Med Ctr, Dept Pathol, Columbus, OH 43210 USA
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2007年 / 82卷 / 03期
关键词：
D O I：
10.1002/ajh.20746
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：251 / 251
页数：1
相关论文
共 50 条
  • [31] Significant fraction of ADAMTS13 activity is associated with activated platelets and their micropartictes (PMP): Implication for regulating ADAMTS13 activity.
    Jy, Wenche
    Lin, Andrew
    Bidot, Loreta
    Bang, Jaehoon
    Ahn, Eugene
    Horstman, Lawrence L.
    Jimenez, Joaquin J.
    Bidot, Carlos J.
    Ahn, Yeon-Soong
    BLOOD, 2006, 108 (11) : 317A - 318A
  • [32] Reduced ADAMTS13 activity is associated with an ADAMTS13 SNP, fever and microparticles in a malaria-like model
    Sirima Kraisin
    Attakorn Palasuwan
    Supaluk Popruk
    Duangdao Nantakomol
    Malaria Journal, 13
  • [33] A Rapid and Simple Assay for the Determination of Adamts-13 Activity
    Binder, Nikolaus B.
    Griffiths, Margaret
    Vetr, Helga
    BLOOD, 2016, 128 (22)
  • [34] Relationship between ADAMTS13 activity in clinical remission and the risk of TTP relapse
    Wu, H.
    VOX SANGUINIS, 2008, 95 : 77 - 77
  • [35] Low ADAMTS13 activity in clinical remission predicts the risk of TTP relapses
    Wu, H. M.
    Cataland, S. R.
    Kennedy, M. S.
    Lin, S.
    Jin, M.
    TRANSFUSION, 2007, 47 (03) : 14A - 14A
  • [36] Low ADAMTS13 activity in clinical remission predicts the risk of TTP relapses
    Wu, Haifeng M.
    Casper, T. Charles
    Cataland, Spero R.
    Lin, Shili
    Kennedy, Melanie
    Jin, Ming
    BLOOD, 2007, 110 (11) : 73B - 73B
  • [37] The carboxyl-terminal domains of ADAMTS13 cause substrate-dependent divergence of ADAMTS13 activity.
    Zhou, Wenhua
    Tsai, Han-Mou
    BLOOD, 2006, 108 (11) : 117A - 117A
  • [38] Persistent ADAMTS13 inhibitor delays recovery of ADAMTS13 activity in caplacizumab-treated Japanese patients with iTTP
    Saito, Kenki
    Sakai, Kazuya
    Kubo, Masayuki
    Azumi, Hidekazu
    Hamamura, Atsushi
    Ochi, Shinichi
    Amagase, Hiroki
    Kunieda, Hisako
    Ogawa, Yoshiyuki
    Yagi, Hideo
    Matsumoto, Masanori
    BLOOD ADVANCES, 2024, 8 (09) : 2151 - 2159
  • [39] Persistent reduction of ADAMTS13 activity in acute ischemic stroke which is independent of VWF levels and ADAMTS13 inhibitor
    Baker, R., I
    Thom, J.
    Hughes, Q.
    Plaimauer, B.
    Scheiflinger, F.
    Rottensteiner, H.
    Hankey, G.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 732 - 733
  • [40] Fatal congenital thrombotic thrombocytopenic purpura with apparent ADAMTS13 inhibitor:: in vitro inhibition of ADAMTS13 activity by hemoglobin
    Studt, JD
    Hovinga, JAK
    Antoine, G
    Hermann, M
    Rieger, M
    Scheiflinger, F
    Lämmle, B
    BLOOD, 2005, 105 (02) : 542 - 544
12345